Insider · CIK 0001870865
Paul Badawi
Files at SGHT (Sight Sciences, Inc.). First filing Jan 6, 2025, latest Oct 5, 2026.
Paul Badawi files SEC Form 4 as CEO, president, director and 10% owner at SGHT (Sight Sciences, Inc.). Since Jan 6, 2025, Paul Badawi has reported 0 open-market buys worth $0 and 9 open-market sells worth $1.2M, the latest filed on Oct 5, 2026.
A track record needs three past buys with six months of prices behind them; Paul Badawi has 0, so none is measured yet.
The newest scored trade: sold $268k of SGHT on Oct 1, 2026, filed Oct 5, 2026, scored 33 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $802k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGHT: Sight Sciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Sight Sciences, Inc. | $268k 29,653 shares | -0% | +182% from low-4% from high | |
| 30Weak | Sight Sciences, Inc. | $108k 29,244 shares | -0% | +75% from low-60% from high | |
| 31Weak | Sight Sciences, Inc. | $148k 22,362 shares | -0% | +210% from low-29% from high | |
| 54Moderate | Sight Sciences, Inc. | $277k 37,226 shares | -1% | +258% from low-17% from high | |
| 49Moderate | Sight Sciences, Inc. | $82k 24,441 shares | -0% | +60% from low-46% from high | |
| 50Moderate | Sight Sciences, Inc. | $98k 23,637 shares | -0% | +95% from low-41% from high | |
| 47Moderate | Sight Sciences, Inc. | $56k 24,174 shares | -0% | 0% from low-67% from high | |
| 48Moderate | Sight Sciences, Inc. | $73k 24,819 shares | -0% | - | |
| 46Moderate | Sight Sciences, Inc. | $44k 12,236 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 1, 2025 | SGHT Sight Sciences, Inc. | 24,441 0.05% of outstanding | $82k | Oct 1, 2025 | $98k |
| Jul 1, 2025 | SGHT Sight Sciences, Inc. | 23,637 0.05% of outstanding | $98k | Jul 1, 2025 | $56k |
| Apr 1, 2025 | SGHT Sight Sciences, Inc. | 24,174 0.05% of outstanding | $56k | Apr 1, 2025 | $117k |
| Jan 16, 2025 | SGHT Sight Sciences, Inc. | 24,819 0.05% of outstanding | $73k | Jan 16, 2025 | $44k |
| Jan 2, 2025 | SGHT Sight Sciences, Inc. | 12,236 0.02% of outstanding | $44k | Jan 2, 2025 | $76k |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -29,653 | $9.05 | $268k | 6,092,819 | 8 d ago |
| Apr 1, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -29,244 | $3.70 | $108k | 6,151,156 | Apr 3, 2026 |
| Feb 3, 2026 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +154,560 | $0.00 | $0 | 6,180,400 | Feb 5, 2026 |
| Jan 16, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock10b5-1 | -22,362 | $6.62 | $148k | 6,025,840 | Jan 21, 2026 |
| Jan 2, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -25,356 | $7.43 | $188k | 5,937,146 | Jan 6, 2026 |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -11,870 | $7.48 | $89k | 5,925,276 | Jan 6, 2026 |
| Oct 1, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -24,441 | $3.34 | $82k | 5,962,502 | Oct 3, 2025 |
| Jul 1, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -23,637 | $4.15 | $98k | 5,986,943 | Jul 7, 2025 |
| Apr 1, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -24,174 | $2.30 | $56k | 6,010,580 | Apr 3, 2025 |
| Mar 11, 2025 | SGHT Sight Sciences, Inc. | AGrant or award Common Stock | +358,423 | $0.00 | $0 | 6,034,754 | Mar 13, 2025 |
| Jan 16, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -24,819 | $2.92 | $73k | 5,676,331 | Jan 21, 2025 |
| Jan 7, 2025 | SGHT Sight Sciences, Inc. | FTax withholding Common Stock | -12,047 | $3.58 | $43k | 5,701,150 | Jan 10, 2025 |
| Jan 2, 2025 | SGHT Sight Sciences, Inc. | SOpen-market sale Common Stock | -12,236 | $3.60 | $44k | 5,713,197 | Jan 6, 2025 |
Questions about Paul Badawi
Answered from the filings on this page, as of the latest one.
Is Paul Badawi buying or selling?
In the last 12 months Paul Badawi reported 0 open-market buys worth $0 and 4 open-market sells worth $802k on SEC Form 4; the latest was sold $268k of SGHT on Oct 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Paul Badawi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Badawi has 0.
Where does Paul Badawi file Form 4?
Paul Badawi has filed Form 4 at SGHT (Sight Sciences, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.